Kaplan–Meier curves revealed that the expression of these genes significantly affected the survival outcome of GBM (IDH-wildtype) patients (p < 0.05; Log-rank test; Figure 2) in the TCGA-GBM cohort. The gene discussed is IDH1; the disease is glioblastoma.